prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT SENTINEL #1, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 2: LYMPH NODE, LEFT SENTINEL #2, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 3: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. (NEILTRATING DUCIAL CARCINOMA (3A, 3B, 3C, 3D, 3E, AND 3F). THE TUMOR COMES TO WITHIN 1.0 MM. FROM THE NEAREST ANTERIOR RESECTION MARGIN (3A AND 3B). B. THE TUMOR SIZE IS 1.5 X 1.2 X 1.1 CM. C. NOTTINGHAM SCORE IS 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1). D. LYMPHOVASCULAR PERMEATION IS NOT APPRECIATED. E. DUCTAL CARCINOMA IN SITU, CRIBRIFORM AND SOLID TYPES, NUCLEAR GRADE 2, REPRESENTING. ABOUT 2% OF TUMOR VOLUME. F. DUCTAL CARCINOMA IN SITU IS ADMIXED WITH INVASIVE TUMOR AND COMES TO WITHIN 1.0 MM FROM. THE NEAREST ANTERIOR RESECTION MARGIN. G. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. H. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID CHANGES, DUCTAL EPITHELIAL HYPERPLASIA,. COLUMNAR CELL CHANGES AND ASSOCIATED MULTIFOCAL MICROCALCIFICATIONS. I. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER-. 2/NEU WERE PREVIOUSLY PERFORMED ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - POSITIVE, HER-2/NEU - NEGATIVE. (SCORE +1). PART 4: LYMPH NODE, LEFT SENTINEL #3, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 5: LYMPH NODE, LEFT SENTINEL #4, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Cribriform, Solid, DCIS admixed with invasive carcinoma, Percent of tumor occupied. by in situ component: 2 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 1 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T PATHOLOGIC: NON-NEOPLASTIC STAGE, BREAST TISSUE: Fibroadenoma, FCD. pT1c. N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pNo. ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: positive. positive. HER2/NEU: zero or 1+.

expanded version (tokens=1372) : 
 The breast pathology report reveals the following details:

- The patient underwent a segmental mastectomy procedure on their left breast.
- The lymph nodes examined in sentinel #1, #2, #3, and #4 were found to be free of any tumor.
- A neoplastic invasive ductal carcinoma was identified in the left breast, located 1.0 mm from the nearest anterior margin.
- The tumor measured 1.5 x 1.2 x 1.1 cm and is a ductal adenocarcinoma without angiolymphatic invasion.
- The Nottingham score for the tumor was determined to be 6/9, with a nuclear grade of 2, tubule formation of 3, and mitotic activity score of 1. This resulted in a Nottingham grade of 2.
- The infiltration of tumor within lymphovascular spaces is not appreciated.
- Ductal carcinoma in situ (DCIS) of cribriform and solid types with a nuclear grade of 2 represented about 2% of the tumor volume.
- The DCIS was admixed with invasive carcinoma and also located 1.0 mm from the nearest anterior margin.
- Multifocal microcalcifications were observed in association with fibrocystic changes, fibroadenomatoid changes, and ductal epithelial hyperplasia.
- Ancillary testing (IHC) performed previously reported Estrogen Receptor-positive, Progesterone Receptor-positive, HER2

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1534) : 
 The patient's left breast segmental mastectomy biopsy showed invasive ductal carcinoma with associated DCIS and fibrocystic changes. Lymph nodes were negative for tumor involvement, and surgical margins were positive but within 1 mm of the lesion. Nottingham score is 6 out of 9 (Nuclear grade: 2, Tubule formation: 3, Mitotic activity: 1), indicative of a Grade 2 tumor. IHC shows Estrogen receptor-positive, progesterone receptor-positive and HER-2/Neu-negative (score +1).

